dudley clinical services limited
dudley clinical services limited Company Information
Company Number
08245934
Website
-Registered Address
trust hq russells hall hospital, dudley, england, DY1 2HQ
Industry
Other human health activities
Telephone
01384234222
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
dudley group nhs foundation trust 100%
dudley clinical services limited Estimated Valuation
The estimated valuation range for dudley clinical services limited, derived from financial data as of March 2023 and the most recent industry multiples, is between £921k to £3.5m
dudley clinical services limited Estimated Valuation
The estimated valuation range for dudley clinical services limited, derived from financial data as of March 2023 and the most recent industry multiples, is between £921k to £3.5m
dudley clinical services limited Estimated Valuation
The estimated valuation range for dudley clinical services limited, derived from financial data as of March 2023 and the most recent industry multiples, is between £921k to £3.5m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Dudley Clinical Services Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Dudley Clinical Services Limited Overview
Dudley Clinical Services Limited is a live company located in england, DY1 2HQ with a Companies House number of 08245934. It operates in the other human health activities sector, SIC Code 86900. Founded in October 2012, it's largest shareholder is dudley group nhs foundation trust with a 100% stake. Dudley Clinical Services Limited is a established, mid sized company, Pomanda has estimated its turnover at £5.9m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dudley Clinical Services Limited Health Check
Pomanda's financial health check has awarded Dudley Clinical Services Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £5.9m, make it larger than the average company (£715k)
£5.9m - Dudley Clinical Services Limited
£715k - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (5.3%)
- Dudley Clinical Services Limited
5.3% - Industry AVG
Production
with a gross margin of 12.1%, this company has a higher cost of product (35.9%)
12.1% - Dudley Clinical Services Limited
35.9% - Industry AVG
Profitability
an operating margin of 4.8% make it less profitable than the average company (6.1%)
4.8% - Dudley Clinical Services Limited
6.1% - Industry AVG
Employees
with 63 employees, this is above the industry average (19)
63 - Dudley Clinical Services Limited
19 - Industry AVG
Pay Structure
on an average salary of £1k, the company has a lower pay structure (£24.6k)
£1k - Dudley Clinical Services Limited
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £93k, this is more efficient (£43.3k)
£93k - Dudley Clinical Services Limited
£43.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Dudley Clinical Services Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Dudley Clinical Services Limited
- - Industry AVG
Stock Days
it holds stock equivalent to 14 days, this is more than average (9 days)
14 days - Dudley Clinical Services Limited
9 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 135 weeks, this is average cash available to meet short term requirements (141 weeks)
135 weeks - Dudley Clinical Services Limited
141 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.5%, this is a similar level of debt than the average (21.7%)
19.5% - Dudley Clinical Services Limited
21.7% - Industry AVG
dudley clinical services limited Credit Report and Business Information
Dudley Clinical Services Limited Competitor Analysis
Perform a competitor analysis for dudley clinical services limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
dudley clinical services limited Ownership
DUDLEY CLINICAL SERVICES LIMITED group structure
Dudley Clinical Services Limited has no subsidiary companies.
Ultimate parent company
DUDLEY GROUP NHS FOUNDATION TRUST
#0102852
1 parent
DUDLEY CLINICAL SERVICES LIMITED
08245934
dudley clinical services limited directors
Dudley Clinical Services Limited currently has 4 directors. The longest serving directors include Mr Christopher Walker (Oct 2012) and Mr Adam Thomas (Jul 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Christopher Walker | England | 49 years | Oct 2012 | - | Director |
| Mr Adam Thomas | 42 years | Jul 2019 | - | Director | |
| Mr Lowell Williams | 61 years | Apr 2021 | - | Director | |
| Mr Vij Randeniya | 63 years | Aug 2022 | - | Director |
DUDLEY CLINICAL SERVICES LIMITED financials
Dudley Clinical Services Limited's latest turnover from March 2023 is £5.9 million and the company has net assets of £1.4 million. According to their latest financial statements, Dudley Clinical Services Limited has 63 employees and maintains cash reserves of £896 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5,862,000 | 5,948,000 | 5,949,000 | 5,858,000 | 5,101,000 | 5,407,000 | 5,414,000 | 4,386,000 | 3,288,000 | 2,038,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 5,152,000 | 5,335,000 | 5,344,000 | 5,224,000 | 4,544,000 | 4,845,000 | 4,871,000 | 3,889,000 | 2,835,000 | 1,733,000 |
| Gross Profit | 710,000 | 613,000 | 605,000 | 634,000 | 557,000 | 562,000 | 543,000 | 497,000 | 453,000 | 305,000 |
| Admin Expenses | 427,000 | 422,000 | 422,000 | 381,000 | 364,000 | 371,000 | 376,000 | 370,000 | 360,000 | 240,000 |
| Operating Profit | 283,000 | 191,000 | 183,000 | 253,000 | 193,000 | 191,000 | 167,000 | 127,000 | 93,000 | 65,000 |
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 1,000 | 1,000 | 2,000 | 2,000 | 2,000 | 1,000 | 0 |
| Pre-Tax Profit | 283,000 | 191,000 | 183,000 | 254,000 | 194,000 | 193,000 | 169,000 | 129,000 | 94,000 | 65,000 |
| Tax | -54,000 | -36,000 | -35,000 | -48,000 | -37,000 | -37,000 | -34,000 | -25,000 | -19,000 | -13,000 |
| Profit After Tax | 229,000 | 155,000 | 148,000 | 206,000 | 157,000 | 156,000 | 135,000 | 104,000 | 75,000 | 52,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 229,000 | 155,000 | 148,000 | 206,000 | 157,000 | 156,000 | 135,000 | 104,000 | 75,000 | 52,000 |
| Employee Costs | 63,000 | 64,000 | 66,000 | 64,000 | 55,000 | 65,000 | 72,000 | 71,000 | 48,000 | 0 |
| Number Of Employees | 63 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 |
| EBITDA* | 283,000 | 191,000 | 183,000 | 253,000 | 193,000 | 191,000 | 167,000 | 127,000 | 93,000 | 65,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 204,000 | 253,000 | 316,000 | 194,000 | 172,000 | 144,000 | 167,000 | 202,000 | 236,000 | 263,000 |
| Trade Debtors | 0 | 0 | 189,000 | 273,000 | 47,000 | 0 | 0 | 140,000 | 92,000 | 0 |
| Group Debtors | 493,000 | 150,000 | 0 | 0 | 0 | 88,000 | 0 | 0 | 0 | 0 |
| Misc Debtors | 167,000 | 190,000 | 182,000 | 203,000 | 164,000 | 156,000 | 174,000 | 167,000 | 155,000 | 102,000 |
| Cash | 896,000 | 828,000 | 845,000 | 706,000 | 659,000 | 403,000 | 590,000 | 187,000 | 233,000 | 245,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,760,000 | 1,421,000 | 1,532,000 | 1,376,000 | 1,042,000 | 791,000 | 931,000 | 696,000 | 716,000 | 610,000 |
| total assets | 1,760,000 | 1,421,000 | 1,532,000 | 1,376,000 | 1,042,000 | 791,000 | 931,000 | 696,000 | 716,000 | 610,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28,000 | 37,000 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 343,000 | 233,000 | 499,000 | 491,000 | 363,000 | 269,000 | 565,000 | 437,000 | 552,000 | 558,000 |
| total current liabilities | 343,000 | 233,000 | 499,000 | 491,000 | 363,000 | 269,000 | 565,000 | 465,000 | 589,000 | 558,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 343,000 | 233,000 | 499,000 | 491,000 | 363,000 | 269,000 | 565,000 | 465,000 | 589,000 | 558,000 |
| net assets | 1,417,000 | 1,188,000 | 1,033,000 | 885,000 | 679,000 | 522,000 | 366,000 | 231,000 | 127,000 | 52,000 |
| total shareholders funds | 1,417,000 | 1,188,000 | 1,033,000 | 885,000 | 679,000 | 522,000 | 366,000 | 231,000 | 127,000 | 52,000 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | 283,000 | 191,000 | 183,000 | 253,000 | 193,000 | 191,000 | 167,000 | 127,000 | 93,000 | 65,000 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -54,000 | -36,000 | -35,000 | -48,000 | -37,000 | -37,000 | -34,000 | -25,000 | -19,000 | -13,000 |
| Stock | -49,000 | -63,000 | 122,000 | 22,000 | 28,000 | -23,000 | -35,000 | -34,000 | -27,000 | 263,000 |
| Debtors | 320,000 | -31,000 | -105,000 | 265,000 | -33,000 | 70,000 | -133,000 | 60,000 | 145,000 | 102,000 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | -28,000 | -9,000 | 37,000 | 0 |
| Accruals and Deferred Income | 110,000 | -266,000 | 8,000 | 128,000 | 94,000 | -296,000 | 128,000 | -115,000 | -6,000 | 558,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 68,000 | -17,000 | 139,000 | 46,000 | 255,000 | -189,000 | 401,000 | -48,000 | -13,000 | 245,000 |
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | 0 | 0 | 0 | 1,000 | 1,000 | 2,000 | 2,000 | 2,000 | 1,000 | 0 |
| cash flow from financing | 0 | 0 | 0 | 1,000 | 1,000 | 2,000 | 2,000 | 2,000 | 1,000 | 0 |
| cash and cash equivalents | ||||||||||
| cash | 68,000 | -17,000 | 139,000 | 47,000 | 256,000 | -187,000 | 403,000 | -46,000 | -12,000 | 245,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 68,000 | -17,000 | 139,000 | 47,000 | 256,000 | -187,000 | 403,000 | -46,000 | -12,000 | 245,000 |
P&L
March 2023turnover
5.9m
-1%
operating profit
283k
+48%
gross margin
12.2%
+17.52%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
1.4m
+0.19%
total assets
1.8m
+0.24%
cash
896k
+0.08%
net assets
Total assets minus all liabilities
dudley clinical services limited company details
company number
08245934
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
October 2012
age
12
accounts
Full Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
trust hq russells hall hospital, dudley, england, DY1 2HQ
last accounts submitted
March 2023
dudley clinical services limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dudley clinical services limited.
dudley clinical services limited Companies House Filings - See Documents
| date | description | view/download |
|---|
